Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited) - USD ($)
Series H Preferred Stock [Member]
Preferred Stock [Member]
Series H-3 Preferred Stock [Member]
Preferred Stock [Member]
Series H-6 Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2020 $ 2,709 $ 64,509,724 $ (25,154,817) $ 39,357,616
Balance, shares at Dec. 31, 2020 8 1,234 50 27,088,584      
Stock Based Compensation         1,699,423   1,699,423
Sale of common stock, net of fees $ 804 58,269,025   58,269,829
Sale of common stock, net of fees, shares       8,035,835      
Exercise Warrants       $ 1 99,999   100,000
Exercise of warrants, shares       13,642      
Exercise Options       $ 7 183,418   183,425
Exercise Options, shares       74,987      
Net Loss           (5,633,833) (5,633,833)
Balance at Mar. 31, 2021 $ 3,521 124,761,589 (30,788,650) 93,976,460
Balance, shares at Mar. 31, 2021 8 1,234 50 35,213,048      
Balance at Dec. 31, 2021 $ 3,687 131,654,776 (58,234,231) 73,424,232
Balance, shares at Dec. 31, 2021 8 1,234 50 36,866,956      
Stock Based Compensation         288,110   288,110
Vesting of Restricted Stock $ 4 329,377   $ 329,381
Vested Restricted Stock, shares       43,000      
Exercise Options, shares            
Net Loss           (4,578,660) $ (4,578,660)
Balance at Mar. 31, 2022 $ 3,691 $ 132,272,263 $ (62,812,891) $ 69,463,063
Balance, shares at Mar. 31, 2022 8 1,234 50 36,909,956